drug	disease	classification	notes	drug_url	disease_urlAcetylsalicylic acid	systemic lupus erythematosus	disease-modifying		http://www.drugbank.ca/drugs/DB00945	http://www.disease-ontology.org/term/DOID%3A9074Alprazolam	systemic scleroderma	symptomatic		http://www.drugbank.ca/drugs/DB00404	http://www.disease-ontology.org/term/DOID%3A418Baclofen	multiple sclerosis	symptomatic		http://www.drugbank.ca/drugs/DB00181	http://www.disease-ontology.org/term/DOID%3A2377Bupropion	panic disorder	disease-modifying	if it reduces "flares" of panic attacks	http://www.drugbank.ca/drugs/DB01156	http://www.disease-ontology.org/term/DOID%3A594Captopril	rheumatoid arthritis	?	some research in rats says this may be helpful in RA	http://www.drugbank.ca/drugs/DB01197	http://www.disease-ontology.org/term/DOID%3A7148Cisplatin	hematologic cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00515	http://www.disease-ontology.org/term/DOID%3A2531Cladribine	hematologic cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00242	http://www.disease-ontology.org/term/DOID%3A2531Clopidogrel	coronary artery disease	disease-modifying	helps to prevent disease worsening	http://www.drugbank.ca/drugs/DB00758	http://www.disease-ontology.org/term/DOID%3A3393Cocaine	dental caries	symptomatic		http://www.drugbank.ca/drugs/DB00907	http://www.disease-ontology.org/term/DOID%3A216Conjugated Estrogens	osteoporosis	disease-modifying		http://www.drugbank.ca/drugs/DB00286	http://www.disease-ontology.org/term/DOID%3A11476Dextroamphetamine	narcolepsy	symptomatic		http://www.drugbank.ca/drugs/DB01576	http://www.disease-ontology.org/term/DOID%3A8986Dextrothyroxine	coronary artery disease	disease-modifying	cholesterol lowering agent; pulled due to cardiac side effects	http://www.drugbank.ca/drugs/DB00509	http://www.disease-ontology.org/term/DOID%3A3393Epirubicin	liver cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00445	http://www.disease-ontology.org/term/DOID%3A3571Ethinyl Estradiol	breast cancer	disease-modifying	estrogens can stimulate progression of ER+BrCa but high-dose estrogens may suppress their growth	http://www.drugbank.ca/drugs/DB00977	http://www.disease-ontology.org/term/DOID%3A1612Etidronic acid	osteoporosis	disease-modifying		http://www.drugbank.ca/drugs/DB01077	http://www.disease-ontology.org/term/DOID%3A11476Etoposide	hematologic cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00773	http://www.disease-ontology.org/term/DOID%3A2531Etoposide	muscle cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00773	http://www.disease-ontology.org/term/DOID%3A4045Flunisolide	allergic rhinitis	symptomatic		http://www.drugbank.ca/drugs/DB00180	http://www.disease-ontology.org/term/DOID%3A4481Hydrochlorothiazide	hypertension	disease-modifying		http://www.drugbank.ca/drugs/DB00999	http://www.disease-ontology.org/term/DOID%3A10763Hydroxyurea	head and neck cancer	disease-modifying		http://www.drugbank.ca/drugs/DB01005	http://www.disease-ontology.org/term/DOID%3A11934Ibuprofen	osteoarthritis	symptomatic 		http://www.drugbank.ca/drugs/DB01050	http://www.disease-ontology.org/term/DOID%3A8398Indinavir	acquired immunodeficiency syndrome	disease-modifying		http://www.drugbank.ca/drugs/DB00224	http://www.disease-ontology.org/term/DOID%3A635L-DOPA	restless legs syndrome	symptomatic 		http://www.drugbank.ca/drugs/DB01235	http://www.disease-ontology.org/term/DOID%3A0050425Linagliptin	type 2 diabetes mellitus	disease-modifying		http://www.drugbank.ca/drugs/DB08882	http://www.disease-ontology.org/term/DOID%3A9352Meloxicam	rheumatoid arthritis	symptomatic		http://www.drugbank.ca/drugs/DB00814	http://www.disease-ontology.org/term/DOID%3A7148Metformin	kidney cancer	symptomatic	some studies suggest it may be beneficial but not one from 2013	http://www.drugbank.ca/drugs/DB00331	http://www.disease-ontology.org/term/DOID%3A263Metoclopramide	prostate cancer	? Symptomatic	cant find anything that suggests it is disease modifying	http://www.drugbank.ca/drugs/DB01233	http://www.disease-ontology.org/term/DOID%3A10283Metoprolol	hypertension	disease-modifying		http://www.drugbank.ca/drugs/DB00264	http://www.disease-ontology.org/term/DOID%3A10763Mitoxantrone	prostate cancer	disease-modifying		http://www.drugbank.ca/drugs/DB01204	http://www.disease-ontology.org/term/DOID%3A10283Morphine	coronary artery disease	symptomatic		http://www.drugbank.ca/drugs/DB00295	http://www.disease-ontology.org/term/DOID%3A3393Mycophenolic acid	psoriasis	disease-modifying		http://www.drugbank.ca/drugs/DB01024	http://www.disease-ontology.org/term/DOID%3A8893Nisoldipine	hypertension	disease-modifying		http://www.drugbank.ca/drugs/DB00401	http://www.disease-ontology.org/term/DOID%3A10763Omeprazole	systemic scleroderma	? Symptomatic	although could be considered disease mod if it protects against esophogeal complications of scleroderma	http://www.drugbank.ca/drugs/DB00338	http://www.disease-ontology.org/term/DOID%3A418Orlistat	obesity	disease-modifying	prevents absorption of fats 	http://www.drugbank.ca/drugs/DB01083	http://www.disease-ontology.org/term/DOID%3A9970Oxandrolone	osteoporosis	symptomatic	relieves bone pain	http://www.drugbank.ca/drugs/DB00621	http://www.disease-ontology.org/term/DOID%3A11476Prazosin	hypertension	disease-modifying		http://www.drugbank.ca/drugs/DB00457	http://www.disease-ontology.org/term/DOID%3A10763Prednisolone	ankylosing spondylitis	symptomatic		http://www.drugbank.ca/drugs/DB00860	http://www.disease-ontology.org/term/DOID%3A7147Prednisolone	chronic obstructive pulmonary disease	? Disease modifying		http://www.drugbank.ca/drugs/DB00860	http://www.disease-ontology.org/term/DOID%3A3083Prednisolone	multiple sclerosis	symptomatic		http://www.drugbank.ca/drugs/DB00860	http://www.disease-ontology.org/term/DOID%3A2377Prednisone	atopic dermatitis	symptomatic		http://www.drugbank.ca/drugs/DB00635	http://www.disease-ontology.org/term/DOID%3A3310Propofol	epilepsy syndrome	symptomatic		http://www.drugbank.ca/drugs/DB00818	http://www.disease-ontology.org/term/DOID%3A1826Quinapril	hypertension	disease-modifying		http://www.drugbank.ca/drugs/DB00881	http://www.disease-ontology.org/term/DOID%3A10763Sibutramine	obesity	disease-modifying	enhances satiety via CNS	http://www.drugbank.ca/drugs/DB01105	http://www.disease-ontology.org/term/DOID%3A9970Thiotepa	sarcoma	disease-modifying		http://www.drugbank.ca/drugs/DB04572	http://www.disease-ontology.org/term/DOID%3A1115Tiagabine	bipolar disorder	disease-modifying		http://www.drugbank.ca/drugs/DB00906	http://www.disease-ontology.org/term/DOID%3A3312Tirofiban	coronary artery disease	disease-modifying		http://www.drugbank.ca/drugs/DB00775	http://www.disease-ontology.org/term/DOID%3A3393Topotecan	peripheral nervous system neoplasm	disease-modifying		http://www.drugbank.ca/drugs/DB01030	http://www.disease-ontology.org/term/DOID%3A1192Triamcinolone	psoriatic arthritis	? disease-modifying		http://www.drugbank.ca/drugs/DB00620	http://www.disease-ontology.org/term/DOID%3A9008Vitamin C	prostate cancer	disease-modifying		http://www.drugbank.ca/drugs/DB00126	http://www.disease-ontology.org/term/DOID%3A10283Zileuton	asthma	disease-modifying	oral, inhibitis leukotrienes	http://www.drugbank.ca/drugs/DB00744	http://www.disease-ontology.org/term/DOID%3A2841